DKNG three-lens brief
Evidence-based stock research on DKNG. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved +3.20% yesterday. · Trading at 12% of its 52-week range — deep in the lower band.
- Moved +3.20% yesterday.
- Trading at 12% of its 52-week range — deep in the lower band.
- Underperforming SPY by 11.0pp over 30 days.
- Analyst mean target $34.86 — 47% above current (34 analysts).
- Debt-to-equity of 299.3 — balance-sheet-heavy.
DKNG closed at $23.73 (+3.20%) as of 2026-05-04. Market cap: $11.77B. Positives: moved +3.20% yesterday.; analyst mean target $34.86 — 47% above current (34 analysts).. Concerns: trading at 12% of its 52-week range — deep in the lower band.; underperforming SPY by 11.0pp over 30 days.. Last quarter: Revenue $1.99B, net income $136.43M, free cash flow $605.93M.
Why three lenses on DKNG, not one.
A single reasoning model has blind spots it doesn’t know about. We examine DKNGacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/DKNG" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath DKNG brief"></iframe>